BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
12/4/2020 9:56:58 AM | Browse: 696 | Download: 1601
 |
Received |
|
2020-05-15 08:45 |
|
Peer-Review Started |
|
2020-05-15 08:46 |
 |
To Make the First Decision |
|
|
|
Return for Revision |
|
2020-11-03 06:00 |
|
Revised |
|
2020-11-12 11:28 |
|
Second Decision |
|
2020-11-19 08:34 |
|
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Executive Editor-in-Chief |
|
2020-11-21 05:52 |
|
Articles in Press |
|
2020-11-21 05:52 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2020-12-01 00:42 |
|
Publish the Manuscript Online |
|
2020-12-04 09:56 |
| ISSN |
2307-8960 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2020. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Infectious Diseases |
| Manuscript Type |
Editorial |
| Article Title |
Understanding the immunopathogenesis of COVID-19: Its implication for therapeutic strategy
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Yukihiro Shimizu |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Yukihiro Shimizu, MD, PhD, Director, Director, Doctor, Doctor, Gastroenterology Center, Nanto Municipal Hospital, 938 Inami, Nanto 932-0211, Toyama, Japan. rsf14240@nifty.com |
| Key Words |
COVID-19; SARS-CoV-2; Immune response; Antibody; Viral kinetics; Treatment |
| Core Tip |
Since the coronavirus disease 2019 (COVID-19) is caused by severe acute respiratory syndrome-coronavirus 2 (SARS-CoV-2), the core therapeutic strategy should be aimed at the eradication of the virus. Unfortunately, there have been no antiviral drugs proven to be effective for this viral infection. The pathogenesis of SARS-CoV-2 is formed by the interaction between the viral infection and the immune response to the virus, and the various clinical features observed in patients with COVID-19 could be due to differences in host immune responses. Moreover, therapeutic strategies should be based on both viral kinetics and the immune response. This editorial summarizes current understanding about immune responses in patients infected with SARS-CoV-2 and provides clues to therapeutic strategies based on this information. |
| Publish Date |
2020-12-04 09:56 |
| Citation |
Shimizu Y. Understanding the immunopathogenesis of COVID-19: Its implication for therapeutic strategy. World J Clin Cases 2020; 8(23): 5835-5843 |
| URL |
https://www.wjgnet.com/2307-8960/full/v8/i23/5835.htm |
| DOI |
https://dx.doi.org/10.12998/wjcc.v8.i23.5835 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
